Are you ready for a different approach to managing MCAS (Mast Cell Activation Syndrome) and histamine intolerance?  In mainstream healthcare these conditions are differentiated into are two distinct medical conditions that are commonly referred to as the result of an abnormal response to histamine.  Although both conditions share similar symptoms, the underlying mechanisms differ, and proper diagnosis and treatment are necessary.

​

MCAS occurs when mast cells, a type of immune cell, become overactive and release excessive amounts of histamine and other inflammatory substances in response to triggers that would not normally cause a reaction.  Histamine intolerance on the other hand is a condition in which the body has difficulty breaking down histamine.  You can experience histamine intolerance and MCAS in combination to each other or you can experience one or the other condition on their own. 

​

My approach to managing these types of conditions are to first assess the current environment you are exposed to and help to support you with correcting or mitigating the effects of those environmental pressures. 

​

Info you may not have heard:  Histamine is made from an amino acid called Histidine. 

Histidine, like many organic molecules, can absorb ultra violet light.

This absorption is due to its molecular structure, via its aromatic imidazole ring.  Therefore Histidine has the ability to respond to LIGHT.  The other intriguing piece of the puzzle is that Histidine also converts to another compound called urocanic acid that works with melanin to absorb UV and offer protection from the sun.  From a quantum biology perspective specific protocols used to  build your solar tolerance could is a key intervention in calming hyper-activated mast cells and reducing histamine responses.